Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $458000.0.

  • Marimed's Net Cash Flow rose 21336.63% to $458000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year increase of 803.8%. This contributed to the annual value of -$7.4 million for FY2024, which is 25002.04% down from last year.
  • As of Q3 2025, Marimed's Net Cash Flow stood at $458000.0, which was up 21336.63% from -$1.1 million recorded in Q2 2025.
  • Marimed's Net Cash Flow's 5-year high stood at $11.9 million during Q1 2023, with a 5-year trough of -$25.6 million in Q2 2022.
  • For the 5-year period, Marimed's Net Cash Flow averaged around $189315.8, with its median value being $458000.0 (2025).
  • Per our database at Business Quant, Marimed's Net Cash Flow skyrocketed by 1060547.37% in 2021 and then plummeted by 60726.48% in 2022.
  • Over the past 5 years, Marimed's Net Cash Flow (Quarter) stood at $4.1 million in 2021, then plummeted by 133.54% to -$1.4 million in 2022, then skyrocketed by 200.73% to $1.4 million in 2023, then plummeted by 280.81% to -$2.5 million in 2024, then surged by 118.28% to $458000.0 in 2025.
  • Its Net Cash Flow stands at $458000.0 for Q3 2025, versus -$1.1 million for Q2 2025 and -$81000.0 for Q1 2025.